0S9E logo

Extendicare LSE:0S9E Stock Report

Last Price

CA$10.56

Market Cap

CA$927.3m

7D

0%

1Y

51.5%

Updated

07 Feb, 2025

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

Extendicare Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Extendicare
Historical stock prices
Current Share PriceCA$10.56
52 Week HighCA$10.74
52 Week LowCA$6.63
Beta1.3
1 Month Change1.36%
3 Month Changen/a
1 Year Change51.51%
3 Year Change40.61%
5 Year Changen/a
Change since IPO40.80%

Recent News & Updates

Recent updates

Shareholder Returns

0S9EGB HealthcareGB Market
7D0%0.1%1.0%
1Y51.5%-21.9%12.1%

Return vs Industry: 0S9E exceeded the UK Healthcare industry which returned -21.9% over the past year.

Return vs Market: 0S9E exceeded the UK Market which returned 12.1% over the past year.

Price Volatility

Is 0S9E's price volatile compared to industry and market?
0S9E volatility
0S9E Average Weekly Movementn/a
Healthcare Industry Average Movement6.1%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.7%
10% least volatile stocks in GB Market2.7%

Stable Share Price: 0S9E's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine 0S9E's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1968n/aMichael Guerrierewww.extendicare.com

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands.

Extendicare Inc. Fundamentals Summary

How do Extendicare's earnings and revenue compare to its market cap?
0S9E fundamental statistics
Market capCA$927.32m
Earnings (TTM)CA$63.90m
Revenue (TTM)CA$1.42b

14.5x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0S9E income statement (TTM)
RevenueCA$1.42b
Cost of RevenueCA$1.22b
Gross ProfitCA$204.05m
Other ExpensesCA$140.14m
EarningsCA$63.90m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 27, 2025

Earnings per share (EPS)0.77
Gross Margin14.32%
Net Profit Margin4.48%
Debt/Equity Ratio244.3%

How did 0S9E perform over the long term?

See historical performance and comparison

Dividends

4.3%

Current Dividend Yield

63%

Payout Ratio

Does 0S9E pay a reliable dividends?

See 0S9E dividend history and benchmarks
When do you need to buy 0S9E by to receive an upcoming dividend?
Extendicare dividend dates
Ex Dividend DateJan 31 2025
Dividend Pay DateFeb 14 2025
Days until Ex dividend8 days
Days until Dividend pay date6 days

Does 0S9E pay a reliable dividends?

See 0S9E dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 18:33
End of Day Share Price 2025/01/28 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Extendicare Inc. is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tom CallaghanBMO Capital Markets Equity Research
Douglas LoeByron Capital Markets
Tania Armstrong-WhitworthCanaccord Genuity